AMERISAFE, Inc. (AMSF) Balance Sheet

Total liabilities fell more modestly, from $940.4M to $872.8M, so the balance sheet is shrinking on both sides but equity is compressing at a faster rate. This pattern may reflect shareholder distributions and periodic underwriting losses rather than a deliberate deleveraging, and investors should monitor whether retained earnings can rebuild the capital base. The trajectory warrants further investigation into the split between capital returns and organic capital generation.

The 136.6% loss ratio in 2026Q2 against a 35.5% ratio in 2025Q4 suggests that quarterly reserve adequacy cannot be assessed from these figures alone, since reserve development detail is not provided. Liabilities of roughly $873M to $940M relative to the claims flow indicate a long-tail reserve book where small estimate changes could materially move reported earnings. Reserve development history would be needed to determine whether prior-year releases have been masking underlying loss trends.

Statutory RBC ratios are not included in the supplied data, so regulatory capital adequacy cannot be confirmed and the book-value trend is used only as a proxy. A declining equity ratio may limit capacity for future buybacks or acquisitions without additional earnings support. Investors should monitor statutory capital disclosures before drawing firm conclusions about solvency headroom.

Without reported cash or fixed-income liquidity figures, it is not possible to test whether liquid assets cover expected claims payouts across the volatile quarters shown. Claims outflows reaching $125.6M in a single quarter illustrate why this gap matters for assessing liquidity. Reinsurance recoverable balances are also absent, so counterparty exposure cannot be evaluated from this dataset.